Procaps Group SA (PROC)
2.727
0.00 (0.00%)
USD |
NASDAQ |
Apr 26, 16:00
Procaps Group Enterprise Value: 570.84M for April 26, 2024
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| April 26, 2024 | 570.84M |
| April 25, 2024 | 570.84M |
| April 24, 2024 | 573.41M |
| April 23, 2024 | 573.42M |
| April 22, 2024 | 568.91M |
| April 19, 2024 | 568.91M |
| April 18, 2024 | 567.78M |
| April 17, 2024 | 565.53M |
| April 16, 2024 | 551.99M |
| April 15, 2024 | 556.50M |
| April 12, 2024 | 566.65M |
| April 11, 2024 | 566.74M |
| April 10, 2024 | 562.14M |
| April 09, 2024 | 556.50M |
| April 08, 2024 | 562.14M |
| April 05, 2024 | 584.71M |
| April 04, 2024 | 584.71M |
| April 03, 2024 | 579.06M |
| April 02, 2024 | 576.81M |
| April 01, 2024 | 591.48M |
| March 28, 2024 | 590.37M |
| March 27, 2024 | 576.81M |
| March 26, 2024 | 601.74M |
| March 25, 2024 | 601.63M |
| March 22, 2024 | 613.48M |
| Date | Value |
|---|---|
| March 21, 2024 | 613.48M |
| March 20, 2024 | 613.48M |
| March 19, 2024 | 623.07M |
| March 18, 2024 | 629.84M |
| March 15, 2024 | 617.42M |
| March 14, 2024 | 617.42M |
| March 13, 2024 | 618.17M |
| March 12, 2024 | 602.76M |
| March 11, 2024 | 629.84M |
| March 08, 2024 | 617.42M |
| March 07, 2024 | 606.14M |
| March 06, 2024 | 608.40M |
| March 05, 2024 | 636.61M |
| March 04, 2024 | 626.45M |
| March 01, 2024 | 599.37M |
| February 29, 2024 | 592.60M |
| February 28, 2024 | 599.94M |
| February 27, 2024 | 608.40M |
| February 26, 2024 | 614.04M |
| February 23, 2024 | 634.91M |
| February 22, 2024 | 666.44M |
| February 21, 2024 | 666.44M |
| February 20, 2024 | 646.76M |
| February 16, 2024 | 680.61M |
| February 15, 2024 | 665.94M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
509.11M
Minimum
Oct 23 2023
1.294B
Maximum
Oct 20 2021
899.44M
Average
800.47M
Median
Jan 09 2023
Enterprise Value Benchmarks
| Alvotech | 4.905B |
| Moolec Science SA | 60.48M |
| Perspective Therapeutics Inc | 919.81M |
| Electromed Inc | 125.27M |
| Xtant Medical Holdings Inc | 139.78M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | 8.194M |
| Revenue (Quarterly) | 118.41M |
| Total Expenses (Quarterly) | 105.36M |
| EPS Diluted (Quarterly) | 0.08 |
| Gross Profit Margin (Quarterly) | 57.77% |
| Profit Margin (Quarterly) | 6.92% |
| Earnings Yield | 19.07% |
| Operating Earnings Yield | 11.76% |
| Normalized Earnings Yield | 1.132 |